1. Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial. Issue 2 (1st February 2016) Authors: Karuturi, Meghan; Younes, Anas; Fayad, Luis; Kwak, Larry; Pro, Barbara; Shah, Jatin; Oki, Yasuhiro; Simien, Rinata; Liboon, Mary Joy; Hutto, Toni; Feng, Lei; Horowitz, Sandra; Nieto, Yago; Anderlini, Paolo; Alousi, Amin; Popat, Uday; Medeiros, L. Jeffrey; Miranda, Roberto; Fanale, Michelle Journal: Leukemia & lymphoma Issue: Volume 57:Issue 2(2016:Feb.) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study. Issue 6 (20th February 2021) Authors: Pelster, Meredith S.; Gruschkus, Stephen K.; Bassett, Roland; Gombos, Dan S.; Shephard, Michael; Posada, Liberty; Glover, Maura S.; Simien, Rinata; Diab, Adi; Hwu, Patrick; Carter, Brett W.; Patel, Sapna P. Journal: Journal of clinical oncology Issue: Volume 39:Issue 6(2021) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗